Review on development of potential inhibitors of SARS-CoV-2 main protease (M Pro ).

Soumya Gulab KatreAlpana Jagdish AsnaniKumar PratyushNilima Gangadhar SakharkarAshwini Gajanan BhopeKanchan Tekram SawarkarVaibhav Santosh Nimbekar

Published in: Future journal of pharmaceutical sciences (2022)

inhibitors are fast progressing. The focus of this review is on recent advancements in the quest for small-molecule inhibitors of the severe acute respiratory syndrome coronavirus 2 main protease.

Keyphrases

respiratory syndrome coronavirus
sars cov
small molecule
coronavirus disease
climate change
human health